ࡱ> PRO 3bjbj 4Jrr+00000DDD8|4,Df(  +$2!j03  3300CCC300C3CCk 40!=!"!033C33333C3333333!333333333 : University of North Carolina-Chapel Hill Consent Form for participation in a study- Parent Form (Biomedical) ________________________________________________________________________ IRB Study #14-0539 IRB Version Date: March 7, 2014 Title of Study: CKD Parent-Youth Project Persons in charge of study: Ali Annaim, BS Where they work at -Chapel Hill. -Chapel Hill Phone number: 919-966-2561 Email Address: ali_annaim@med.unc.edu Other people who work on the study: Sarah Cohen, Kristi Bickford Source of funding for the study: Renal Research Institute Study Contact: Kristi Bickford Study Contact telephone number: 919-966-2561 Study Contact email: HYPERLINK "mailto:kristi_bickford@med.unc.edu" kristi_bickford@med.unc.edu ________________________________________________________________ What are some general things you should know about research studies? You are being asked to take part in a research study. To join the study is voluntary. You may refuse to join, or you may withdraw your consent to be in the study, for any reason, without penalty. Research studies are designed to obtain new knowledge. This new information may help people in the future. You may not receive any direct benefit from being in the research study. There also may be risks to being in research studies. Details about this study are discussed below. It is important that you understand this information so that you can make an informed choice about being in this research study. You will be given a copy of this consent form. You should ask the researchers named above, or staff members who may assist them, any questions you have about this study at any time. What is the purpose of this study? The purpose of this study is to learn more about howparents of children diagnosed with a chronic health condition learn about their childs condition, and we also want understand how the parenting style that is used may relate to the way that parents learn about their childs condition. You are being asked to be in the study because your child has chronic health condition. Information about your child and other patients will be combined to help us improve how parents can learn about their childs what we teach transition-age patients and their families about chronic health conditions and about growing into healthier adults. Are there any reasons you should not be in this study? You should not be in this study if you do not feel comfortable talking about various aspects of your health (i.e., physical, mental, sexual, etc). How many people will take part in this study? There will be approximately200 people in this research study. 100 parents and 100 children will be included in this study. How long will your part in this study last? The study will only consist of todays interaction in clinic. The entire set of questions should take an hour to complete. The next sectionprovides an estimate ofhow long each tool/questionnaire you may be asked to complete will take you. You can spend as much time or as little time with the researcher(s) as you desire. Your participation is completely voluntary and at your discretion. What will happen if you take part in the study? If you choose to participate in this study, you may be asked to complete some or all of the following questionnaires during the course of your study enrollment. You will be asked to completeall of them during one visit. If you are unable to complete the questions, they can be emailed to you since they are available online. REALM (Rapid Estimate of Adult/Adolescent Literacy in Medicine): You may be asked to read a list ofcommon medical words and lay terms for body parts and illnesses aloud. This will help your medical team know how to bettercommunicate with and teachyou about your condition and medications. It will take no more than 2-3 minutes to complete and you will only be asked to do this once. The TRxANSITION Scale(parent version): You may be asked to answer32 questions related to your health condition knowledge and disease management skills to find out what you know and dont know. A researcher will ask you the questions out loud. Ittakes an average of 7 minutes toanswer all of the questions. Kidney Knowledge (KiKs) survey: You will be asked 19 questions that will help us to understand how much you know about kidney disease. A researcher will ask you the questions out loud. Ittakes an average of 7 minutes toanswer all of the questions. Parental Authority Questionnaire-Revised: You will asked 30 questions that will assess your parenting style. A researcher will ask you the questions out loud. Ittakes an average of 7 minutes toanswer all of the questions. Learning Preference: You will be asked 5 questions to learn how you gather information about your childs condition. This will take approximately 5 minutes to complete. Focused Interview: You will be asked a series of questions to understand how you use the internet and or games in general. This series of questions will take an average of 15-30 minutes. These questionnaires may help researchers learn more about what can be helpful tounderstand how parents learn about their childs chronic health condition. Answering these questionnaires is completely voluntary and you maychoose not tocomplete any questionnaire or answer any questionsat any time.You will be seen only during regularly scheduled clinic appointments.No additional visits/appointments will be required or necessary for participation in this study. We are also asking you to answer some interview questions to help us understand how learn about your childs condition. We will also ask about how you interact with games and the internet for education. What are the possible benefits from being in this study? Research is designed to benefit society by gaining new knowledge. We do not know of any direct benefits that you will get from being in this study, but your being in the study may help other parents learn about their childs condition. What are the possible risks or discomforts involved from being in this study? The following situations may cause minimal discomfort in participants: a discussion your childs chronic health condition, discussion of how you learn, discussion of your use of the internet, and the discussion of the use of games. To minimize discomfort, these issues will be discussed with you in private and your answers will be kept confidential. They will not be disclosed to parents/primary caregivers/legal guardians and will not be shared with doctors/nurses. There may be uncommon or previously unknown risks. You should report any problems to the researcher. What if we learn about new findings or information during the study? You will be given any new information gained during the course of the study that might affect your willingness to continue your participation. How will your privacy be protected? Any personally identifiable information (i.e.,name, date of birth, address, etc) we collect from you will be stored in a password protected database that only the researchersnamed in this study will be permitted access to. Data and information may be shared with other researchers and/or health care providers working with them, but alldata/info will be coded with a unique study ID. Any questionnaire you complete or that is administered to you willhave this ID instead of yourname. The researchers on this study have had training in protecting the privacy and rights of patients. Participants will not be identified in any report or publication about this study. Although every effort will be made to keep research records private, there may be times when federal or state law requires the disclosure of such records, including personal information. This is very unlikely, but if disclosure is ever required, -Chapel Hill will take steps allowable by law to protect the privacy of personal information. In some cases, your information in this research study could be reviewed by representatives of the University, research sponsors, or government agencies (for example, the FDA) for purposes such as quality control or safety. At some point in time, the researcher(s) may ask you if they can digitally record an interview with you. This digital recording will not contain any personally identifiable information (i.e., name, date of birth, address, etc), only your voice. The recording will only be used to obtain qualitative data. You have the choice of allowing the researcher(s) to record you or not. Please indicate your decision below. Check the line that best matches your choice: _____ OK to record me during the study _____ Not OK to record me during the study What if you want to stop before your part in the study is complete? You can withdraw from this study at any time, without penalty. The investigators also have the right to stop your participation at any time. This could be because you have had an unexpected reaction, or have failed to follow instructions, or because the entire study has been stopped. Will you receive anything for being in this study? You will receive $20 for being in this study. Will it cost you anything to be in this study? It will not cost you anything to be in this study. Who is sponsoring this study? This research is funded by the Renal Research Institute and the Children's Hospital. This means that the research team is being paid by the sponsor for doing the study. The researchers do not, however, have a direct financial interest with the sponsor or in the final results of the study. What if you have questions about this study? You have the right to ask, and have answered, any questions you may have about this research. If you have questions about the study (including payments), complaints, concerns, or if a research-related injury occurs, you should contact the researchers listed on the first page of this form. What if you have questions about your rights as a research participant? All research on human volunteers is reviewed by a committee that works to protect your rights and welfare. If you have questions or concerns about your rights as a research subject, or if you would like to obtain information or offer input, you may contact the Institutional Review Board at 919-966-3113 or by email to IRB_subjects@unc.edu.  Participants Agreement: I have read the information provided above. I have asked all the questions I have at this time. I voluntarily agree to participate in this research study. ______________________________________________________ Signature of Research Participant ____________________ Date ______________________________________________________ Printed Name of Research Participant ______________________________________________________ Signature of Research Team Member Obtaining Consent ____________________ Date ______________________________________________________ Printed Name of Research Team Member Obtaining Consent     07-0352 Adult Consent Form Page  PAGE \* Arabic \* MERGEFORMAT 1 of  NUMPAGES \* Arabic \* MERGEFORMAT 5 TZ  % ' k 碓y[FB4)hyvhx&CJaJhyvhx&0J>*CJaJhx&)h7?5B*CJOJPJQJ\aJph::;;jh7?hKz5>*B*CJOJPJQJU\aJph6l2h7?hKz5>*B*CJOJPJQJ\aJph6lh7?hKzCJOJQJaJ%jh7?hKzCJOJQJUaJ2h7?hKz5>*B*CJOJPJQJ\aJph::;/h7?h5B*CJOJPJQJ\aJph::;/h7?hKz5B*CJOJPJQJ\aJph::;)m  B f 3 5 T edE)^edRgdI d-DM edE)^gd)l[d-DM edE)^gdKzBD =D|)_ 5?_欞}qdWdWhyvh)l[0JOJQJhyvhx&0JOJQJhyvhx&<OJQJhyvh#OJQJhyvhXOJQJhyvhx&OJQJhyvhx&0J>*OJQJhyvhI 0J>*CJaJhyvh#CJaJhyvh:*CJaJhyvh)l[CJaJhyvh'.CJaJhyvhx&CJaJhyvhx&0J>*CJaJEOPR,^JPQapõêÚ{k^NAhyvh3CJ^JaJhyvh35>*CJ^JaJhyvhI CJPJaJhyvh70J>*CJPJaJ"hyvhx&0J>*CJH*PJaJhyvhx&CJPJaJhyvhx&0J>*CJPJaJhyvhgOJQJhyvhx&0J>*OJQJhyvhx&OJQJhyvhx&0JOJQJhyvh ROJQJhyvh)l[0JOJQJhyvh#0JOJQJJz[bo0q0s0t0u0,1.111$IfedE)^edE)^ & Fddd[$\$edE)^gd7 & Fddd[$\$edE)^gd3zZ[o^abYz{ 󹬹~s~eeZOhyvh ROJQJhyvh}OJQJhyvhx&0J>*OJQJhyvh]OJQJhyvh3OJQJhyvh6?OJQJhyvhx&OJQJhyvh3CJPJaJhyvh7CJPJaJhyvh75>*CJ^JaJhyvhwo=CJPJaJhyvhwo=CJ^JaJhyvh35>*CJ^JaJhyvh3CJPJaJ ' * 7 _ m } "X"" #*R*r+++++,8,U,--./q0r0t0u00.122333333 3 3 33߻ߪߝߝ|x|x|x|xhpQjhpQUhyvhCJaJhyvhI 0J>*OJQJhyvhx&CJPJaJ!jhyvhx&CJPJUaJhyvhOJQJhyvhx&0J>*OJQJhyvh-2OJQJhyvhx&OJQJhyvh ROJQJhyvh}OJQJ-112222r22IDedE)^Wkd $$IfedE)^0U"BB t634BaitE)^$IfWkd$$IfedE)^0U"BB t634BaitE)^2222333IDBedE)^Wkd$$IfedE)^0U"BB t634BaitE)^$IfWkd~$$IfedE)^0U"BB t634BaitE)^33333 3 3 3333333333333333  $HAgdI  dgd@333333333.3/34353V3W3X3Y3]3^3333333333333hyvhCJaJhpQh5mHnHu h@5jhx&5UhI h"h@21h:px&/ =!"#$% Dd<P  3 3"((o$$IfedE)^!vh#v#v :V  t6,534BitE)^o$$IfedE)^!vh#v#v :V  t6,534BitE)^o$$IfedE)^!vh#v#v :V  t6,534BitE)^o$$IfedE)^!vh#v#v :V  t6,534BitE)^j 666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ OJPJQJ_HmH nH sH tH J`J x&Normal dCJ_HaJmH sH tH DA`D Default Paragraph FontRi@R 0 Table Normal4 l4a (k ( 0No List >@> @0HeaderdH$.. @0 Header Char> @> @0FooterdH$.!. @0 Footer CharR@2R @0 Balloon Text dCJOJQJ^JaJNoAN @0Balloon Text CharCJOJQJ^JaJ`^@R` x&0 Normal (Web)ddd[$\$CJOJPJQJ^JaJ*W`a* x&`Strong5\0Oq0 x& eform_yellowPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3N)cbJ uV4(Tn 7_?m-ٛ{UBwznʜ"Z xJZp; {/<P;,)''KQk5qpN8KGbe Sd̛\17 pa>SR! 3K4'+rzQ TTIIvt]Kc⫲K#v5+|D~O@%\w_nN[L9KqgVhn R!y+Un;*&/HrT >>\ t=.Tġ S; Z~!P9giCڧ!# B,;X=ۻ,I2UWV9$lk=Aj;{AP79|s*Y;̠[MCۿhf]o{oY=1kyVV5E8Vk+֜\80X4D)!!?*|fv u"xA@T_q64)kڬuV7 t '%;i9s9x,ڎ-45xd8?ǘd/Y|t &LILJ`& -Gt/PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!0C)theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] +J  33 $1233!"#+X2TV[!L# @0(  B S  ?_GoBack++++ NY++++++ + + ++4+Y+]++++Be'+!!((+++++ + + ++++33333%%   E O P + , ^ JJ '*++++.+/+4+Y+]+++K:!rj^`.^`.pp^p`.@ @ ^@ `.^`.^`.^`.^`.PP^P`.K:!rE)^RE)^.+gq68l% I u vI!x&:*M0(1-20J5wo=6?7?SMpQ)l[Ukd}; R,~soyv@'.XX[Z3{ 7]Kz#"3++@+@UnknownG*Ax Times New Roman5Symbol3. *Cx Arial7.@Calibri5. .[`)TahomaA$BCambria Math"1h2#'jZ)cJ)GH k$Nk$N20**;QHP  $P@2!xx Slattery, John AMCACC03NEPHWS15  Oh+'0  4 @ L Xdlt|Slattery, John A Normal.dotmMCACC03NEPHWS15 3Microsoft Office Word@r@M2@ NG@Dx)k$՜.+,D՜.+,X hp  0The University of North Carolina at Chapel HillN*  Title 8@ _PID_HLINKSAM#mailto:kristi_bickford@med.unc.edu  !"#$%'()*+,-/0123456789:;<=>@ABCDEFHIJKLMNQRoot Entry FK4SData &1Table.!WordDocument4JSummaryInformation(?DocumentSummaryInformation8GCompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q